• Our Medicines

    We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2016, we invested $4.9 billion in R&D, which included the discovery and development of new medicines.

    Below is a list of our company's marketed products. Any linked documents and websites are intended only for U.S. residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.?

    Report Side Effects or Product Quality Complaints

    (toll free US only)

    Report Side Effects or Product Quality Complaints about Legacy Celgene Products?(ABRAXANE?,?IDHIFA?,?INREBIC?, ISTODAX?, POMALYST?, REBLOZYL?, REVLIMID?, THALOMID?, VIDAZA?)
    ?

    Learn More

    ABRAXANE? (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)

    Triangle Icon

    AZACTAM? (aztreonam for injection, USP)

    Triangle Icon

    EVOTAZ? (atazanavir and cobicistat)

    Triangle Icon

    HYDREA? (hydroxyurea)

    Triangle Icon

    KENALOG?-10 (triamcinolone acetonide)

    Triangle Icon

    KENALOG? -40 (triamcinolone acetonide) and?
    KENALOG? -80 (triamcinolone acetonide)

    Triangle Icon

    PRAVACHOL? (pravastatin sodium)

    Triangle Icon

    REBLOZYL? (luspatercept-aamt)

    Triangle Icon

    VIDAZA? (azacitidine)

    Triangle Icon

    Legacy Brands


    Please click below to see the Full U.S. Prescribing Information, including?Boxed WARNING?and Medication Guide/Patient Information?for:

    能看AV永久免费的APP